Company NewCardio, Inc. Other OTC
Equities
NWCI
US65106G1004
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cardiac Diagnosis
100.0
%
| 0 | nan % | 0 | 100.0 % | +∞% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | +∞% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jess Emery Jones
CEO | Chief Executive Officer | 45 | 08-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jess Emery Jones
CEO | Chief Executive Officer | 45 | 08-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,295 | 0 | 0 | 75.73 % |
Stock B | 1 | 33,210,807 | 25,150,108 ( 75.73 %) | 62,500 ( 0.1882 %) | |
Stock C | 0 | 12,116 | 0 | 0 |
Company contact information
NewCardio, Inc.
103 Carnegie Center Suite 300
08540-6235, Princeton
+
Sector
1st Jan change | Capi. | |
---|---|---|
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |